A recent study found that among people who were overweight or obese, taking metformin during a COVID infection reduced the risk of developing long COVID by 40%.
Vinita Srivastava, The Conversation; Boké Saisi, The Conversation et Kikachi Memeh, The Conversation
As the use of Ozempic, a drug for diabetes, slams into the mainstream as a weight-loss method, will the drug’s use impact our concept of fatness? And how does fatness intersect with race and class?
Influencers have been enthusiastically claiming its success in helping them lose weight, with their posts viewed by millions. You might be surprised what the evidence shows.
In a controversial move in 2021, drug-funding agency Pharmac fully subsidised new diabetes drugs for Māori and Pacific patients. Could the result help set a precedent?
Ozempic uses semaglutide to mimic the role of a hormone naturally produced by the body to create feelings of fullness. Certain foods can do the same thing.
Nine in ten of all deaths in New Zealand are caused by non-communicable diseases such as heart disease and diabetes. Better use of research evidence could save lives and healthcare dollars.
For parents, encouraging healthy family diets for children from the time they are babies is one way to keep children’s blood sugar levels in check. The Indonesian government can do more to help too.
Scientists are figuring out why so many diseases and conditions, including diabetes, inflammation and parasitic infection, can affect our eye health. But there are ways to protect your macula.
You’ve probably heard of the drug semaglutide or Ozempic, the diabetes medication being used for weight loss. So what are the risks and benefits? And who should have access to it?
The risk of developing eye complications is high in young people with Type 2 diabetes, which is increasingly affecting children and adolescents, especially those who are more sedentary.
On the centenary of insulin’s first use, doctors, researchers and people with diabetes are asking why New Zealand lags other countries in funding the latest devices to monitor blood sugar.
In Canada, 14.4 per cent of South Asians have Type 2 diabetes, the highest prevalence of any other ethnic group in the country. Why is this population so disproportionately affected by diabetes?
Improving diabetes care in South Africa requires strong will and support from health authorities, introduction of clinical information systems, the use of technology and digital solutions.
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand